Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.88 is 21% below its 5-year average of 4.92, near the low end of its 5-year range (1.19–21.04).
As of the fiscal period ended Tuesday, June 30, 2026. 23.66% above its 12-month average of 3.14.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.88.
QUICK RATIO (ACID-TEST)
3.88
QUICK RATIO (ACID-TEST) AVG TTM
3.14
QUICK RATIO (ACID-TEST) AVG 3Y
2.57
QUICK RATIO (ACID-TEST) AVG 5Y
4.92
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.66%
CURRENT VS 3Y AVG
+50.81%
CURRENT VS 5Y AVG
-21.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.85
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+36.06%
vs the sector median at left
Acurx Pharmaceuticals, Inc.
Market Cap
$5.63M
Quick Ratio (Acid-Test)
3.88
TTM Avg
3.14
3Y Avg
2.57
5Y Avg
4.92
Market Cap
$5.36M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$6.03M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$6.09M
Quick Ratio (Acid-Test)
119.39
TTM Avg
100.04
3Y Avg
53.35
5Y Avg
40.07
Market Cap
$6.10M
Quick Ratio (Acid-Test)
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$4.99M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.18
3Y Avg
0.40
5Y Avg
0.95
Market Cap
$4.96M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | $5.63M | 3.88 | 3.14 | 2.57 | 4.92 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | 2.35 | 1.31 | 0.84 | 0.78 |
| Imunon, Inc. (IMNN)vs › | $5.21M | 1.82 | 1.99 | 2.53 | 3.43 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 119.39 | 100.04 | 53.35 | 40.07 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 17.15 | 11.86 | 7.50 | 9.06 |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.55 | 1.77 | 4.96 | 6.03 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | 0.09 | 0.18 | 0.40 | 0.95 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | 1.84 | 1.72 | 1.97 | 1.97 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 0.93 | 1.44 | 2.71 | 3.16 |
Quick Ratio
3.88
Excludes inventory
Current Ratio
3.88
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.88 |
| 2026-03-31 | 3.78 |
| 2025-12-31 | 3.18 |
| 2025-09-30 | 2.47 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 1.93 |
| 2024-12-31 | 1.19 |
| 2024-09-30 | 1.80 |
| 2024-06-30 | 2.09 |
| 2024-03-31 | 2.93 |
| 2023-12-31 | 2.53 |
| 2023-09-30 | 2.22 |
| 2023-06-30 | 3.06 |
| 2023-03-31 | 3.56 |
| 2022-12-31 | 4.55 |
| 2022-09-30 | 9.26 |
| 2022-06-30 | 19.43 |
| 2022-03-31 | 17.89 |
| 2021-12-31 | 15.71 |
| 2021-09-30 | 21.04 |
| 2021-06-30 | 9.09 |
| 2021-03-31 | 5.73 |
| 2020-12-31 | 6.82 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
